JASON GRABER

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry BEVERLY HILLS, CA NPI 1730213745

General Payments — all program years on this page

$1,613.18

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 78
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $410.43 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $366.2615
Education $44.173

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $188.1110
Neurocrine BioSciences, Inc. $103.573
Takeda Pharmaceuticals U.S.A., Inc. $91.484
E.R. Squibb & Sons, L.L.C. $27.271

By program year

Program yearAmountRecords
2018 $111.176
2019 $157.917
2020 $35.732
2021 $192.8410
2022 $185.9910
2023 $519.1125
2024 $410.4318

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101678064 E.R. Squibb & Sons, L.L.C. $27.27 10/09/2024 Education Undisputed 01/23/2026 View at CMS
1103826766 ABBVIE INC. $12.24 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103826768 ABBVIE INC. $29.29 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103826770 ABBVIE INC. $20.77 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103826772 ABBVIE INC. $20.96 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103826774 ABBVIE INC. $26.37 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103826776 ABBVIE INC. $29.88 06/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103826778 ABBVIE INC. $14.00 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103826780 ABBVIE INC. $17.70 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104195902 ABBVIE INC. $8.45 02/01/2024 Education Undisputed 01/23/2026 View at CMS
1104195904 ABBVIE INC. $8.45 02/01/2024 Education Undisputed 01/23/2026 View at CMS
1137561183 Takeda Pharmaceuticals U.S.A., Inc. $17.20 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137561187 Takeda Pharmaceuticals U.S.A., Inc. $26.53 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137561191 Takeda Pharmaceuticals U.S.A., Inc. $19.52 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137561195 Takeda Pharmaceuticals U.S.A., Inc. $28.23 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150818002 Neurocrine Biosciences, Inc. $35.99 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150819958 Neurocrine Biosciences, Inc. $34.02 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150820514 Neurocrine Biosciences, Inc. $33.56 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.